NCT06082128 2023-10-13
FOCUSau
University of Melbourne
Phase NA Unknown
Clinical Trials
18 trialsNCT04864418 2023-07-20
AST-021p Study in Advanced Solid Tumors
Aston Sci. Inc.
Phase 1 Unknown
NCT04606238 2023-01-10
PETUPAL
University Hospital Heidelberg
Phase NA Unknown
NCT04407013 2022-09-10
Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway
Yonsei University
Phase NA Unknown
NCT05192512 2022-03-03
Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05028218 2021-09-21
A Clinical Study of TQB3824 in Subjects With Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02797795 2021-03-03
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers
Neovia Oncology Ltd.
Phase 1 Unknown
NCT01527331 2020-11-17
A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer
Massachusetts General Hospital
Phase NA Unknown
NCT04376931 2020-07-29
A Prospective Dose Finding Study of Iscador Infusion
HaEmek Medical Center, Israel
Phase 1/2 Unknown
NCT04398875 2020-05-21
Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial
The University of Hong Kong
Phase NA Unknown
NCT04257786 2020-02-06
ovarian cancer
Assiut University
Phase NA Unknown
NCT04124666 2019-12-19
Clinical Study of Granulocyte Infusion for Advanced Cancer
Shanghai East Hospital
Phase 1/2 Unknown
NCT02779699 2019-05-21
A Study of AL2846 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02996838 2019-05-21
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03645200 2019-04-25
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Phase 1 Unknown
NCT03099330 2017-09-18
A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03243643 2017-09-08
HS:Hansoh;
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT01361529 2011-05-27
Safety Study of FLP Injection to Treat Tumor Patients
Acea Bio (Hangzhou) Co., Ltd.
Phase 1 Unknown